Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on December 31st, 2013% A super-resolution optical image of a single viral protein filament, in red, with viral RNA, in green (Eric Alonas and Philip Santangelo, Georgia Institute of Technology)
Researchers at Georgia Institute of Technology and Emory University in Atlanta, and Vanderbilt University in Nashville devised a method with advanced microscopy to follow the process of . . . → Read More: Imaging Technique Captures RNA Viral Infections in Progress
By Alan, on December 30th, 2013% Vaughn Smider (Scripps Research Institute)
Senesco Technologies, a clinical stage biotechnology company in Bridgewater, New Jersey says it has a non-binding merger agreement with Fabrus Inc. in La Jolla, California, a drug-discovery biotechnology firm. Financial details of the merger were not disclosed, although the companies plan to reveal the terms when they finalize . . . → Read More: Clinical, Drug Discovery Biotech Companies Announce Merger
By Alan, on December 30th, 2013% Marburg virus (U.S. Centers for Disease Control and Prevention)
BioCryst Pharmaceuticals Inc., a developer of drugs for infectious and rare diseases in Durham, North Carolina, says National Institutes of Health (NIH) is continuing its contract with the company to develop a treatment for Marburg virus, the cause of a rare but dangerous tropical . . . → Read More: NIH Funding Further Marburg Virus Therapy Development
By Alan, on December 27th, 2013% Flowering sorghum (Agricultural Research Service/USDA)
A new challenge on InnoCentive, sponsored by Advanced Research Projects Agency – Energy (ARPA-E), a division of the U.S. Department of Energy, is seeking new ideas for measuring the potential energy output of biofuel feedstocks, without harming the plant material. The competition, which has a maximum prize of . . . → Read More: ARPA-E Challenge Seeks Bio Energy Measurement Techniques
By Alan, on December 27th, 2013% Zach Lippman (Cold Spring Harbor Laboratory)
Biologists at Cold Spring Harbor Laboratory in New York discovered a genetic process underlying a breeding practice that helps improve yields of tomatoes. The Cold Spring Harbor team led by plant biology professor Zach Lippman, with a colleague from Monash University in Australia, published its findings yesterday . . . → Read More: Genetic Mechanism to Increase Tomato Production Explained
By Alan, on December 26th, 2013% Anders Hakansson (University at Buffalo)
Researchers at University at Buffalo in New York found bacteria associated with strep throat and ear infections to survive outside the body for long periods on toys at a day care center. The team of Buffalo microbiologist Anders Hakansson and doctoral candidates Laura Marks and Ryan Reddinger published . . . → Read More: Bacterial Bioflims Found Surviving on Children’s Toys
By Alan, on December 26th, 2013% (National Institutes of Health)
An international consortium of 70 institutions and companies combined genome-wide analyses with current drug databases to uncover new genomic targets for rheumatoid arthritis, and identify drugs for other diseases with the potential to treat the disorder. The team led by Robert Plenge of Harvard Medical School and the Broad . . . → Read More: Large Genomic Study Finds New Rheumatoid Arthritis Targets
By Alan, on December 24th, 2013%
By Alan, on December 24th, 2013% (National Institutes of Health)
The U.S. Food and Drug Administration yesterday approved a treatment for congenital factor XIII A-subunit deficiency, a rare blood clotting disorder, made by the pharmaceutical company Novo Nordisk, based in Denmark. Tretten, the medication’s brand name, is an engineered biologic designed to prevent bleeding in adults and children with . . . → Read More: FDA Approves Rare Congenital Blood Disease Treatment
By Alan, on December 23rd, 2013% Enrique Saez (Scripps Research Institute)
Biomedical researchers at Scripps Research Institute in La Jolla, California developed a drug discovery method that combines the rapid screening of potential compounds with preclinical tests of the best prospects, and in the process identified a potential new compound to treat type 2 diabetes. The Scripps team led by . . . → Read More: Discovery Process Devised to Better Test Drug Effects
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.